Astrana Health, Inc.
Astrana Health, Inc. (ASTH) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ASTH · as of Jun 8, 2026
Key Statistics
Explore Astrana Health, Inc. Data
asth stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 100.0%
The ASTH analyst consensus is Buy, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $44.60, representing +17.40% upside from the current price of $37.99.
Competitors & Peers
asth competitorsASTH
ACHC
AVAH
HCSG
LFST
MDStock Performance
Full HistoryAbout Astrana Health, Inc.
Astrana Health, Inc. Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners…
what is astrana health, inc. · asth stock overview · astrana health, inc. company profile · who is astrana health, inc. ceo · asth NASDAQ · astrana health, inc. headquarters · astrana health, inc. business segments
About Stock Overview & Key Data
Astrana Health, Inc. (ASTH) is a Healthcare company in the Medical - Care Facilities industry, listed on NASDAQ since Mar 11, 2009. As of the latest trading session, ASTH stock price is $37.99, with a market capitalization of $1.9B. The stock has returned +50.28% over the past 12 months and +53.12% year-to-date.
According to 10 Wall Street analysts, the consensus rating for Astrana Health, Inc. stock is Buy, with an average 12-month price target of $44.60. In fiscal year 2025, Astrana Health, Inc. reported revenue of $3.2B and net income of $22.5M. For detailed data — including Astrana Health, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Astrana Health, Inc. (ASTH) stock price is $37.99. The stock is traded on NASDAQ under the ticker symbol ASTH. The 52-week range is $18.08 – $39.93.